B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MUSK

MOLECULAR TARGET

muscle associated receptor tyrosine kinase

UniProt: O15146NCBI Gene: 459318 compounds

MUSK (muscle associated receptor tyrosine kinase) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MUSK

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1foretinib4.3476
2tozasertib4.3375
3doramapimod4.0657
4quizartinib3.9953
5nintedanib3.6136
6tae 6843.4330
7fedratinib3.4029
8linifanib3.3327
9dovitinib3.0921
10lestaurtinib3.0420
11defosbarasertib2.8917
12r 4062.8316
13kw 24492.6413
14ast 4872.5612
15bms 7548072.309
16su 0148132.208
17Sorafenib1.393
18Crizotinib0.691

About MUSK as a Drug Target

MUSK (muscle associated receptor tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented MUSK interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MUSK inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.